Assyro AI

Orange Book product · Generic (ANDA)

ALLOPURINOL SODIUM

ALLOPURINOL SODIUM

Generic (ANDA)ANDA 212363TE APRX GLAND

At a glance

Jan 26, 2022

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 26, 2022

    4 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ALLOPURINOL SODIUM

Strength

EQ 500MG BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 212363

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ALLOPURINOL SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.